Asia Pharmacogenomics Market By Technology (Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others), By Application (Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others), By End User (Hospitals and Clinics, Research Institutions, and Academic Institutes)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Pharmacogenomics Market
The Asia Pacific Pharmacogenomics Market would witness market growth of 10.2% CAGR during the forecast period (2019-2025). The study of pharmacogenomics deals with the role of genes in drug response in individuals. The growing number of pharmacogenomics-based tests, which are a result of the growing ailments like cancer, tuberculosis, Alzheimer's disease, cardiovascular diseases, and other diseases, is expected to push the market growth. Pharmacogenomics has observed an exponential growth rate in recent years, owing to a rise in preference of patients towards personalized therapy-based medications.
The major factors boosting the growth of pharmacogenomics include technological advancements in molecular diagnostics, such as several molecular biology techniques including polymerase chain reaction, sequencing, microarrays, electrophoresis, mass spectrometry among others, a surge in the preference for using personalized therapy.
Based on Technology, the market is segmented into Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others. Based on Application, the market is segmented into Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others. Based on End User, the market is segmented into Hospitals and Clinics, Research Institutions, and Academic Institutes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.
Scope of the Pharmacogenomics Market Analysis
- Polymerase Chain Reaction
- Mass Spectrometry
- Infectious Diseases
- Neurological Diseases
- Pain management
- Cardiovascular Diseases
By End User
- Hospitals and Clinics
- Research Institutions
- Academic Institutes
- South Korea
- Rest of Asia Pacific
- Abbott Laboratories
- Empire Genomics LLC
- Illumina, Inc.
- OneOme LLC
- Myriad Genetics Inc.
- Thermo Fisher Scientific, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Bayer AG
- Opko Health, Inc.
- Becton, Dickinson and Company
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free